Samsung Bioepis fights to keep biosimilar on German market

The Munich Regional Court has already granted a preliminary injunction restricting the sale of Amgen’s biosimilar version of orphan drug Soliris
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: